The aim of this study was to describe the pattern of blood pressure (BP) distribution in a multiethnic primary care practice in relation to sociodemographic characteristics, lifestyle and risk factors. Another aim was to analyse the quality of diagnosis and effectiveness of hypertension (HT) treatment. In all, 470 adult patients (X16 years old) who visited the Jordbro Health Centre (JHC), Haninge Municipality, participated in this study. A general questionnaire with questions about sociodemographic characteristics, lifestyle, health status and chronic disease was used. Medical records: information on consultations with the general practitioner and prescriptions were collected from the medical records for the year 2001. Furthermore, a medical examination was performed: this consisted of weight, height, systolic (SBP) and diastolic (DBP) blood pressure, and laboratory analyses including fasting blood glucose, serum cholesterol, serum triglycerides, electrocardiogram and spirometry. Out of 464 patients, 114 (24.6%) reported HT. Among the HT patients, 93 (81.6%) had SBP X140 mmHg and 52 (45.6%) DBP X90 mmHg. Among the nonhypertensive patients (n ¼ 350), 120 (34.3%) had SBP X140 mmHg and 50 (14.3%) DBP X90 mmHg. Furthermore, there are some patients with high BP who are unknown or undetected. HT treatment among this population is unsatisfactory and greater efforts are required to identify people with high BP and to ensure that they are managed according to the best available evidence.
Introduction
Hypertension (HT) is a common condition. [1] [2] [3] [4] [5] [6] A Swedish study estimates that, among an adult population of 1.8 million, 60% have mild HT (140-159/90-99 mmHg), 30% moderate HT (160-179/100-109 mmHg) and 10% very high HT (X180/ X110). 1 In a representative German nationwide primary care sample, the point prevalence of HT was reported as 40.1%. 2 Pittrow et al 2 report that BP control was poor in 70.6% of all patients, that is, BP X140/90 mmHg. Another study reported the total point prevalence as 50%. 7 High BP is associated with cardiovascular and stroke risk and organ damage. [8] [9] [10] A Swedish study report that poorly controlled and untreated HT leads to an increased stroke risk. 9 Farsang et al 3 reported from a primary care study from Hungary that the prevalence of undetected HT was 34.6%. The prevalence of HT was about 47% among subjects aged 460 years and about 21% among those aged o50 years. The prevalence in men was 41.5% and in women 30%. They also report that 85% were treated with drugs and the effective BP control (o140/90 mmHg) was about 28%. 11 Achieving BP goals is a challenge for patients and their physicians, and most patients fall short of the goal. [11] [12] [13] [14] [15] For example, Steinman et al 14 found in a survey among primary care patients at Veterans Affairs medical centres that only 43% had BP levels o140/90 mmHg. A Canadian study showed that 24% of hypertensive persons had systolic blood pressure (SBP) of 140-160 mmHg and diastolic blood pressure (DBP) o90 mmHg. 15 Achieving BP control targets in hypertensive patients could prevent cardiovascular events, coronary heart disease, stroke or diabetes. 14, [16] [17] [18] For example, Niklason et al 17 reported that angiotensin-converting enzyme (ACE) inhibitor (ACEI) (The Captopril Prevention Project) reduced the risk of diabetes development among hypertensive patients. Scheen reported that many studies have shown a significant reduction in the incidence of type II diabetes in hypertensive patients with either ACE inhibitors or ARBs for 3-6 years. 18 The main aim of this study was to describe the pattern of BP distribution in a multiethnic primary care practice in relation to sociodemographic characteristics, lifestyle and risk factors. Another aim was to analyse the quality of diagnosis and effectiveness of HT treatment among a consecutive adult population attending Jordbro Health Centre (JHC).
The Committee on Research Ethics at the School of Medicine, Karolinska Institute, approved the study.
Methods

Subjects and setting
A full description of the methodology is provided elsewhere. 19 The patient sample was recruited between October 2002 and April 2003 from adult patients (X16 years old) presenting for routine visits at the JHC. We informed all patients who visited the JHC centre about the study and the patients were consecutively provided with a form to fill in with personal information and stating whether they were interested in the study or not. The patients were requested to complete the questionnaire at the surgery if possible, otherwise they could return it when they had an appointment scheduled for the examination. The registered patients were called to examination consequently according to the register list and they were asked to come to the surgery having fasted for 12 h, that is, they were not allowed to eat, smoke or take medication during the 12 h before the visit and the examination, but were allowed to drink water. The patients were to hand over the questionnaire if it had not been returned, and the answers were checked before the medical examination was performed and the blood samples were taken for analysis.
A nurse well trained in measuring BP performed the measurements and assisted in other practical parts of the survey. The study population consist of patients who were registered during the first 4 weeks, and only six patients provided insufficient data, that is, only six patients did not fulfil the survey completely. If the patients visited the healthcare centre several times during the study period, they were included only once. Owing to practical and financial limitations, we could include only 470 patients in this study.
Measurements
The study consisted of three parts: (a) a general questionnaire, 19, 20 (b) medical record study and (c) a medical examination. The general questionnaire dealing with questions on sociodemographic characteristics, lifestyle, health status, symptoms and medicine use was handed out to the patients. The sociodemographic variables included, in addition to age and gender, family situation (eg whether the patient lived alone, with another adult or with children) and country of birth. They were also asked to indicate the degree of life satisfaction and perceived health. Patients were asked to state whether they had any chronic disease or conditions.
Outcome variables SBP and DBP was measured by a random zero sphygmomanometer with the individual in horizontal position after 5 min rest, and the BP was measured in the right arm. The mean value of three readings was calculated. BP is classified as normotensive (o140/o90); mild HT (140-159/ 90-99 mm g); moderate (160-179/100-109) and severe HT (X180/X110 mmHg). SBP was categorised as o140 or X140; o160 or X160; o180 or X180, while DBP was categorised as 90 or X90; o100 or X100; and o110 or X110. We calculated the distribution of SBP level of o150 and X150 mmHg as well.
Explanatory variables
Sociodemographic variables
The age variable was continuous: Gender, male and female; working, yes and no; country of birth, Nordic countries and rest of the world; living alone was classified as yes or no.
Life satisfaction and perceived health were defined on a seven-point scale, ranging from score 1 'very bad' to score 7 'excellent, could not be better'. Symptoms: The patient questionnaire (PQ) consisted of 13 yes/no questions about the presence of somatic symptoms during the previous month.
Smoking: Smoking was classified as yes or no. Medical examination: BMI, weight in kilograms/ (height in metres); 2 BP, systolic and diastolic; heart rate (pulse) during 1 min; and fasting blood glucose, fasting serum cholesterol and triglycerides. Spirometry: Mean values were calculated for forced expiratory volume for 1 s (FEV 1 ) in % and peak expiratory flow in %. Electrocardiography: The results were judged and grouped into two categories: normal and abnormal if there was any deviation from the normal electrocardiogram (ECG).
Health care and drug utilisation
Information about consultations, number of consultations as well as the number of diagnoses during year 2002 was collected from the computerised medical record, while information about current medicines used at the time of the cross-sectional survey was obtained from the questionnaire.
Chronic disease and diagnoses Common somatic disease consisted of 15 common conditions (HT excluded). The presence of a condition was regarded as 'yes', 1, and the absent as 'no', 0.
HT-related chronic diseases: These consisted of five chronic conditions: diabetes, angina, heart failure, neurological and eye diseases. Number of diagnoses: The total number of medical diagnoses during year 2002 was retrieved from the computerised medical records.
Statistical methods
The data were analysed with the JMP software packages. 21 Standard methods were used to obtain summary statistics such as means, prevalence and other measures. Student and w 2 tests or Fisher's exact test were used to calculate the P-values. All significant tests were two-tailed.
Results
The mean SBP among the studied population and the standard deviations (s. 
BP sociodemographic characteristics
The mean age for those with mild and moderate BP among the whole population was significantly higher than among normotensive patients. BP defined as SBP X140 or X160 mmHg was more common among males, nonworking subjects, those living alone and subjects born in the Nordic countries compared to females, working subjects, those not living alone and subjects born outside the Nordic countries. Also, DBP defined as DBP X90 or X100 mmHg was significantly more common among males and nonworking subjects (data not shown in table).
Among patients who report HT, those with SBP X140, 160 and 180 mmHg are older than those with SBP o140 mmHg (Table 1a) . While those with DBP 90 mmHg and above are younger than those with DBP o90 mmHg (Table 1b) . For DBP, the opposite pattern can be seen, with higher mean age among those with DBP o90 mmHg as compared to those with DBP 90 mmHg and above. More females have SBP X140 mmHg than males, while the pattern is opposite for DBP. For example, among females, 83.9% had SBP X140 mmHg, while among males, the figure was 78.9%. The figures for DBP were 38.7 and 53.9% for females and males, respectively. This is also true for working patients. A higher proportion of working patients have SBP o140 mmHg than nonworking patients. Also, a higher proportion of patients not living alone or born outside the Nordic countries had SBP o140 mmHg as compared to those living alone or born in the Nordic countries. This is also true for DBP o90 mmHg. The same patterns are seen for SBP 160 and 180 mmHg. The number of patients in DBP group 100 and 110 mmHg is too small and the pattern is not quite the same.
For those patients who do not report HT (Table 2a and b), the mean age among patients with SBP and DBP levels X140/90, X160/100 and X180/ 110 mmHg as compared to BP o140/90, 160/100 and 110 mmHg was higher. The proportions of males and females were similar regarding the SBP distribution, but more men than women had DBP level X90, X100 and X110 mmHg. Also, more nonworking subjects, those living alone and born in the Nordic countries had SBP X140 and X160 mmHg than subjects working, living alone or born outside the Nordic countries. More men than women had DBP 490 mmHg. This was also true for nonworking subjects, living alone and born in the Nordic countries as compared to the working patients not living alone or born outside the Nordic countries. However, the number of patients in the SBP X180 mmHg and DBP X100 and X110 mmHg is too small and the pattern is not quite similar.
BP distribution
Among the studied population, for example, 215 (45.7%) had SBP X140 mmHg, 87 (18.5%) 4180 mmHg and 15 (5.3%) X180 mmHg. In all, 103 (21.9%) had only DBP X90 mmHg and 218 (46.7%) had a combined SBP and DBP X140/90 mmHg (Table 3) .
BP among the hypertensive vs nonhypertensive patients Among patients with HT, who accounted for 114 (24.6%) of the surveyed population, 93 (81.6%) had SBP X140 mmHg, 50 (45.6%) X160 mmHg and 17 (14.9%) X180 mmHg, and 52 (45.6%) had DBP X90 mmHg and 94 (45.6%) had a combined SBP and DBP X140/90 mmHg. It is interesting to note that 29 (25.4%) had SBP X180 mmHg or a DBP X100 mmHg. For nonhypertensive patients, 120 (34.3%) had SBP X140 mmHg, 36 (10.3%) 4160 mmHg and eight (2.3) X180 mmHg. A total of 50 (14.3%) had DBP X90 mmHg.
Lifestyle and medical tests in relation to BP
For the whole population, the mean BMI for subjects with SBP X140 mmHg was significantly higher than for those with SBP o140 mmHg. The BMI, for example, of those with SBP X140 mmHg was 28.4 as compared to 27.2 for those with SBP o140 mmHg. Also, the level of fasting blood glucose, serum triglycerides and cholesterol was 
BP and health status
Subjects with low BP report a higher mean number of symptoms. For example, subjects with SBP X160 mmHg report on average 3.4 symptoms as compared to 4.3 among those with SBP o160 mmHg. They also have higher scores for life satisfaction than those with SBP o160 mmHg, but they used more medicines. Also, subjects with SBP X180 mmHg report a lower number of symptoms than those with lower SBP levels. High SBP (4180 mmHg) was also related to higher use of medicines. This was also true for high DBP (490 mmHg).
Hypertensive vs nonhypertensive patients
The hypertensive patients in general report fewer symptoms than nonhypertensive patients (Tables  1a and 2a ). On the other hand, patients with SBP o140 mmHg report more symptoms than those with SBP X140 mmHg. For the nonhypertensive patients, the numbers of symptoms are similar between the BP levels. Hypertensives with SBP X140 mmHg score higher for perceived health and life satisfaction than subjects with SBP o140 mmHg. This phenomenon cannot be seen among the nonhypertensive patients. The hypertensive patients with SBP o140 mmHg have fewer consultations than those with SBP X140 mmHg, but use more medicines. Those with SBP o160 mmHg have more consultations and use more medicines than those with SBP X160 mmHg. For those with SBP X180 mmHg, the pattern is opposite. Patients with SBP o140 mmHg have fewer consultations, use more medicines and have more chronic conditions than those with SBP X140 mmHg. Those with DBP o90 mmHg have more consultations, use more medicines and have more chronic conditions.
However, for the nonhypertensives the pattern is in fact quite opposite.
HT and chronic diseases and medical diagnoses
Among the hypertensive patients, other chronic diseases are more common than among other primary care patients ( Table 1 ). The hypertensive patients in general report 2.5 chronic conditions, confidence interval (CI) 2.2-2.9 as compared to 2.0, CI 1.8-2.2 conditions among the rest of studied population. Also, the other chronic conditions related to HT are much higher among the hypertensive patients, that is, 0.7 (0.6-0.8) vs 0.3 (0.2-0.4). The figures for the number of diagnoses were 1.9 (1.6-2.1) and 1.5 (1.4-1.7) respectively (data not shown in table). Among the hypertensive patients, the ECG was normal in only 32.7% compared to 54.3% among the nonhypertensive patients.
Pharmacotherapy and HT
About 27% of hypertensive patients were treated with two or more combinations of medicines (Table 4 ). Some 31.3% were treated only with betablockers, 10.4 only with diuretics, 13.0% were treated with ACEIs and 3% with calcium channel blocker (CCB). However, the target BP goals were not achieved by any pharmacotherapy, as is evident when we look at the mean SBP, which is higher than the goal of 140 mmHg among all kinds of therapies used. Beta-blockers were the most commonly used drug for all levels of BP, followed by combination therapy among BP X140/90 mmHg and also for SBP X160 and 180 mmHg (Table 5 ). ACE inhibitor is the third drug used among all levels. ACE inhibitor is Table 3 SBP and DBP distribution among the studied population particularly high among the highest SBP level X180 mmHg. Surprising is the low use of combination therapy at all and particularly among the highest BP levels.
Discussion
In spite of the fact that HT is one of the most common diseases among the adult population and that it is well known to be related to cardiovascular diseases, [8] [9] [10] this study shows that HT, defined as SBP X140 mmHg and DBP X90 mmHg, is poorly controlled or undetected. About 46% of this primary care-based study had SBP X140 mmHg and 22% had DBP X90 mmHg. Also, 47% had either SBP X140 mmHg or DBP X90 mmHg. A high proportion, 82%, of self-reported hypertensive patients had SBP X140 mmHg and 45.1% DBP X90 mmHg. Among treated HP patients, SBP X180 mmHg was found among 15% and DBP X110 mmHg among 3.5%. Our findings are, in general, in agreement with other studies regarding poor BP control. [11] [12] [13] [14] [15] The target BP levels are not achieved according to this study, for which there could be several explanations apart from the less aggressive treatment by the general practitioners (GPs). Patient concordance or adherence may play a major role. The side effects of medicine might cause poor adherence. In this study, we did not ask about the dosages or adherence, which is of course a limitation of this study. Another explanation is that mild HT has few symptoms and patients must be highly motivated to use the prescribed medications. Evidently, a high percentage of subjects had elevated BP, and this calls for particular attention, requiring an aggressive approach regarding the monitoring and treatment of HT.
It is interesting that the hypertensive patients report, in general, fewer symptoms than the nonhypertensive, but the hypertensives with the lowest BP level, that is, o140/90 mmHg, have more symptoms than those with BP level X140/90 mmHg. One possible explanation is the side effects of medication. Another explanation is that the BP levels X140/90 mmHg do not necessarily cause any perceptible symptoms and the patients perceive better health with that BP level. It is possible that this reflects a heightened awareness of health and body image that might be present in treated patients.
It has been argued that aggressive BP control is essential to reduce morbidity and mortality. Several programmes and studies show positive effects of pharmacist collaboration. 11 Others suggest a physician-nurse team for managing hypertensive patients. 22 For example, Scisney-Matlock et al 22 have demonstrated lower means for 24-h SBP and DBP among a physician-nurse team in comparison to solely physician-managed care. Ornstein et al 23 suggest that BP control in primary care practice can be much better than reports usually indicate. They also suggest regular monitoring of BP and motivation of the practice to improve patient care. In addition to that, it has been suggested that many physicians have higher BP thresholds for the diagnosis and treatment of HT than the 140/ 90 mmHg criterion recommended. 24 Therefore, further improvements in population HT control will require changes in physician behaviour. 24 However, target BP level may be achievable in clinical trails, but in reality the population characteristics differ in clinical practice and in clinical trails. 23, 25 For example, the Anglo-Scandinavian cardiac outcomes trial (ASCOT) data show that 87% of nondiabetic patients are treated to below 140/90 mmHg. Achieving these BP levels in clinical practice seems unrealistic and can be difficult, particularly when GPs are overloaded. This will need longer consultation times and punctual appointments. 26 The recommended levels according to the Swedish guidelines are SBP below 140 mmHg and for patients with diabetes and renal disease below 130 mmHg. The corresponding figures for DBP are p90 and 80 mmHg. 1 The recommendations from the British Hypertension Society are similar to the Swedish. 27 BP o140/90 mmHg is aimed to be used For patients with diabetes and renal disease, the standard is o130/80 mmHg. 1 The participants in this investigation were voluntary and time limited, and we could only include those who showed an interest; few patients declined to participate or provided incomplete information. It is possible that some selection bias occurred as a result of this consecutive procedure. It is possible, for instance, that our study included only the healthier patients in the JHC because the sickest patients were not able to come to the health centre. The high prevalence of HT in this study is not surprising because HT is one of the most common conditions managed by the GP in Sweden. In addition to that, our results reflect a patient population during a limited time period. Our result is similar to the extrapolated National Heath and Nutrition Examination Survey (NHANES III) data, which report that 24% of the age-adjusted adult US population are hypertensive.
28,29
Limitations
This study has some limitations. As is the case with all questionnaire surveys, there was the possibility that patients exaggerated or under-reported a condition, partly due to difficulties in remembering (recall bias). One other limitation of this study is that the BP was measured on one occasion only and this can naturally overestimate the appropriate prevalence of high BP. On the other hand, other professionals other than physicians measured the BP, and this might have reduced the white coat effect, which is seen when a physician measures BP. 30 The sample size in this study was rather small and therefore conclusions regarding the results of the effect of medicines should be interpreted with caution. It is possible that a few patients with very high BP could have affected the average mean of the presented BP.
HT diagnosis is based on several BP measurements and a single BP measure could be associated with many confounders. The diagnosis of HT should be confirmed and based on several BP measurements. Variability in BP, however, might have had some influence on the measured BP. For example, 24-h blood monitoring could be a better alternative. 31 The strength of this study
In the mean time, the strength of this study is that the BP was measured at random and independently of regular BP monitoring. However, this study has identified several new HT cases, and in fact in the majority of cases, the HT was of mild character and it is possible that this could be reduced by lifestyle changes rather than medication. However, this shows that it is possible that there is a need for further efforts to motivate these individuals to change their lifestyle. Lifestyle modification have been shown to be effective in reducing BP levels. 32, 33 The relation between HT and chronic disease is an important issue. It is obvious that patients with reported HT have more chronic conditions than other primary care patients. They also have more conditions related to HT such as diabetes, angina, heart failure, neurological and eye diseases, and medical diagnoses. Many patients with elevated BP also have other risk factors such as high serum lipids, high BMI, diabetes and are smokers. The metabolic issues are important in managing hypertensive patients. Many studies have shown a high prevalence of metabolic syndrome among population. For example, among the US adult population, the age-adjusted prevalence was estimated at 23-24%. 29 , 34 Jacobson et al 34 report that among those with metabolic syndrome, 76% met the criterion for BP. Risk factor assessment and lifestyle changes with increased physical activity, healthy eating pattern, stress management, smoking cessation and reduced alcohol consumption are cornerstones in the management of HT as well as the metabolic syndrome.
In this study, information on current medicine use was collected from the questionnaire; the patients were instructed to check this at home and if needed we consulted the medical records. We had no access to information on prescription refill rates from the pharmacy because this is not yet possible in Sweden on the individual basis. However, we believe that the information obtained from our patients is reliable and reflects the current use rather than the prescribed use. Nonetheless, we had the possibility to consult the prescribed medications in case there was any doubt that the information provided on medicine use was inadequate. The poor adherence to medicine use or the low rates of consultations cannot be explained by economic reasons because the total cost for medication during 1 year is 1800 SKR (approximately US$240) and for medical care 900 SKR (approximately US$120). Once a person has passed these limits, he or she receives a free card giving entitlement to free medicines and consultations.
Clinical implications
Importantly, the result of this study calls for a more liberal attitude towards BP measurement among primary care patients. In the view of large number of patients with undetected high BP, BP should be controlled among the adult patients consulting the GP undependably of the reason of consultations. Since the BP is increasing with age, this could be cost-effective particularly for subjects aged 50 years and above. Furthermore, the target BP level should be the recommended levels by the national guide lines. However, the white coat effect should be considered. Other health-care professionals could assist in measuring the BP as it is the practice in many Swedish primary care settings in order to reduce the bias, which could be produced by the white coat effect.
In conclusion, we found that about 46% had SBP X140 mmHg. The target BP level probably was not achieved among this population. Furthermore, there are some patients with high BP who are unknown or undetected. HT treatment among this population is unsatisfactory and greater efforts are required to identify people with high BP and to ensure that they are managed according to the best available evidence. There is a potential to improve the diagnostic procedure as well as the monitoring and treatment of HT.
